Benefits
Blood pressure reduction (well-established)
Aburto 2013 (BMJ, PMID 23558164) systematic review of 22 RCTs found ~3.5 mmHg SBP and ~2.0 mmHg DBP reduction with potassium supplementation, with greater effect in hypertensives. A 2024 dose-response meta-analysis (10 RCTs post-2000) confirmed and clarified the dose relationship. Mechanism: renal sodium excretion + vascular smooth muscle relaxation.
Stroke and cardiovascular events — SSaSS landmark trial
Neal 2021 SSaSS trial (NEJM 385:1067-1077, n=20,995 high-risk Chinese adults) found a 25% potassium-enriched salt substitute reduced stroke 14%, major cardiovascular events 13%, and all-cause mortality 12% over 4.74 years. Hyperkalemia was not increased. The strongest outcome-trial evidence to date that increasing potassium intake reduces hard cardiovascular endpoints.
Kidney stone prevention
Potassium citrate alkalinizes urine and reduces urinary calcium excretion, significantly lowering risk of calcium oxalate stone formation. FDA-approved as the prescription drug Urocit-K® for recurrent nephrolithiasis. Higher dietary potassium intake (from fruits, vegetables) is associated with lower lifetime stone risk in cohort studies.
Muscle function and cramp prevention
Potassium is essential for muscle membrane repolarization after each contraction. Hypokalemia causes muscle weakness, cramps, and fatigue — particularly common in athletes with high sweat losses, people on thiazide or loop diuretics, and those with chronic vomiting/diarrhea. Adequate dietary intake (4,000+ mg/day) prevents most muscle-related symptoms.
Fluid balance and electrolyte support
As the dominant intracellular cation, potassium pairs with extracellular sodium to maintain the osmotic gradient that regulates cell volume, nerve impulse transmission, and muscle function. Sweat losses during prolonged exercise are typically 100–300 mg/hour. Low-carb and ketogenic diets increase renal potassium excretion, often requiring more dietary potassium to prevent fatigue and cramping.
Most adults are under-consuming
NHANES surveys show <3% of US adults meet the 4,700 mg/day Adequate Intake from food. Median intake ~2,500 mg/day. USDA food sources: bananas (~422 mg), avocados (~485 mg), white potatoes (~926 mg/medium), beans (~700 mg/cup), spinach (~840 mg/cup cooked), salmon (~534 mg/3 oz), yogurt (~625 mg/cup). Most cardiovascular benefit comes from hitting 3,500+ mg/day, not from supplementation alone.
Mechanism of action
Sodium-potassium ATPase pump
Na+/K+-ATPase pumps maintain the steep potassium gradient across cell membranes, which is the foundation of the resting membrane potential in all excitable cells (neurons, cardiac, skeletal muscle).
Renal natriuresis
High potassium intake stimulates aldosterone-independent renal sodium excretion, directly lowering blood volume and blood pressure. This mechanism explains potassium's antihypertensive effect.
Vascular smooth muscle relaxation
Potassium activates membrane hyperpolarization in vascular smooth muscle cells via K+ channel opening, causing vasodilation and reduced peripheral resistance.
Clinical trials
Cluster-randomized open trial in 20,995 high-risk Chinese adults (history of stroke or ≥60 with hypertension) across 600 rural villages. 75% NaCl + 25% KCl salt substitute vs. regular salt × 4.74 years. Stroke reduced 14% (RR 0.86), major cardiovascular events 13% (RR 0.87), all-cause mortality 12% (RR 0.88). Hyperkalemia not significantly increased. The strongest outcome-trial evidence that potassium-enriched diet reduces hard cardiovascular endpoints.
Systematic review and meta-analysis of 22 RCTs (n=1,606) commissioned by WHO. Increased potassium intake reduced systolic BP by ~3.49 mmHg (95% CI -5.96 to -1.01) and diastolic BP by ~1.96 mmHg (95% CI -3.40 to -0.52) in adults. Effect was greater in hypertensives. Adverse effects (including hyperkalemia) were not increased. Foundation for current WHO and AHA potassium intake recommendations of 3,500+ mg/day.
10 RCTs (4 normotensive, 6 hypertensive) limited to post-2000 trials measuring 24-h urinary potassium excretion as the intervention proxy. Linear, quadratic, and cubic spline models all showed dose-dependent SBP reduction with increasing potassium intake. Greater absolute benefit in hypertensive populations. Reinforces the case for population-level dietary potassium increase rather than supplementation alone.